Product Description
(R)-1-(4-Methoxybenzyl)-2-methyl-1,2,3,4,5,6,7,8-octahydroisoquinoline、67596-84-3
AI Product Description
*The following content is generated by AI and is for reference only.
(R)-1-(4-Methoxybenzyl)-2-methyl-1,2,3,4,5,6,7,8-octahydroisoquinoline is a chiral organic compound belonging to the class of substituted octahydroisoquinolines. Its molecular formula is C17H25NO, reflecting a structure composed of an isoquinoline core partially saturated with eight hydrogen atoms, featuring a 4-methoxybenzyl group at the nitrogen position and a methyl substituent at the second carbon atom in the R-configuration. While specific commercial CAS registry numbers for this exact enantiomer may vary depending on the supplier or batch synthesis method, it typically falls under the broader family of chiral amines used extensively in medicinal chemistry. This molecule serves as a critical chiral building block or intermediate in the pharmaceutical industry, particularly for the asymmetric synthesis of bioactive compounds. The presence of the methoxybenzyl moiety often provides necessary steric bulk and electronic properties that facilitate high enantioselectivity during catalytic reactions or serve as a temporary protecting group strategy in complex molecule assembly. Researchers frequently utilize such chiral scaffolds to develop novel therapeutics targeting neurological disorders, cardiovascular conditions, or other diseases where stereochemistry plays a pivotal role in drug-receptor interactions. The (R)-enantiomer specifically ensures precise spatial orientation, which is essential for optimizing pharmacological activity while minimizing potential side effects associated with racemic mixtures. Beyond pharmaceutical applications, derivatives of this compound may find utility in the development of advanced materials or agrochemicals requiring specific chiral properties. Synthesis usually involves the reductive alkylation of appropriate precursors followed by chiral resolution techniques or asymmetric catalysis to isolate the desired optical isomer. Due to its structural complexity and specific stereochemical requirements, this substance is primarily available through specialized chemical suppliers rather than general commodity markets. Its stability and solubility characteristics make it suitable for various synthetic pathways, including coupling reactions and reduction processes. As the demand for enantiopure drugs grows globally, compounds like (R)-1-(4-Methoxybenzyl)-2-methyl-1,2,3,4,5,6,7,8-octahydroisoquinoline remain indispensable tools for chemists striving to create safer, more effective medical treatments with high precision.